Entrada Therapeutics Inc had a revenue of 1.61M in the quarter ending Sep 30, 2025, with -17.23%. This bring the company's revenue in the last twelve months to 61.52M, Increased -22.59%. In the fiscal year ending Dec 31, 2024, Entrada Therapeutics Inc had annual revenue of 210.78M with 63.38% growth.